tiprankstipranks
Advertisement
Advertisement

AXSM Stock Latest News

Axsome pullback brings attractive entry point, says H.C. Wainwright
The FlyAxsome pullback brings attractive entry point, says H.C. Wainwright
8d ago
AXSM
Ram Selvaraju Reaffirms Buy on Axsome, Maintaining $290 Price Target Amid Solid Execution and AUVELITY Upside Potential
PremiumRatings
Ram Selvaraju Reaffirms Buy on Axsome, Maintaining $290 Price Target Amid Solid Execution and AUVELITY Upside Potential
16d ago
AXSM
Axsome Therapeutics price target raised to $316 from $306 at Mizuho
PremiumThe Fly
Axsome Therapeutics price target raised to $316 from $306 at Mizuho
23d ago
AXSM
Axsome Targets Smoking Cessation With New Phase 3 AXS-05 Trial
PremiumCompany Announcements
Axsome Targets Smoking Cessation With New Phase 3 AXS-05 Trial
25d ago
AXSM
Axsome Therapeutics price target lowered to $297 from $304 at RBC Capital
PremiumThe Fly
Axsome Therapeutics price target lowered to $297 from $304 at RBC Capital
28d ago
AXSM
Analyst Reiterates Buy on Axsome, Sees Undervalued Pipeline Upside with Unchanged $310 Price Target
PremiumRatingsAnalyst Reiterates Buy on Axsome, Sees Undervalued Pipeline Upside with Unchanged $310 Price Target
28d ago
AXSM
Axsome Therapeutics price target raised to $251 from $242 at Morgan Stanley
Premium
The Fly
Axsome Therapeutics price target raised to $251 from $242 at Morgan Stanley
28d ago
AXSM
Axsome Therapeutics price target raised to $275 from $260 at Guggenheim
Premium
The Fly
Axsome Therapeutics price target raised to $275 from $260 at Guggenheim
28d ago
AXSM
Axsome Therapeutics price target raised to $256 from $255 at Wells Fargo
PremiumThe Fly
Axsome Therapeutics price target raised to $256 from $255 at Wells Fargo
29d ago
AXSM
Auvelity Momentum and Pipeline Progress Drive Undervalued Upside in Axsome, Supporting Buy Rating
PremiumRatings
Auvelity Momentum and Pipeline Progress Drive Undervalued Upside in Axsome, Supporting Buy Rating
29d ago
AXSM
Myles Minter Reiterates Buy on Axsome as Auvelity Outperformance and AXS-12 NDA Acceptance Strengthen Long-Term Growth Outlook
PremiumRatings
Myles Minter Reiterates Buy on Axsome as Auvelity Outperformance and AXS-12 NDA Acceptance Strengthen Long-Term Growth Outlook
29d ago
AXSM
Ami Fadia Reiterates Buy on Axsome as Auvelity Outperformance and Alzheimer’s Agitation Launch Momentum Offset Near-Term Margin Pressure
PremiumRatings
Ami Fadia Reiterates Buy on Axsome as Auvelity Outperformance and Alzheimer’s Agitation Launch Momentum Offset Near-Term Margin Pressure
29d ago
AXSM
Axsome reports strong Q2 revenue growth, expanding launches
PremiumCompany AnnouncementsAxsome reports strong Q2 revenue growth, expanding launches
29d ago
8K
AXSM
Axsome Therapeutics reports Q2 EPS (99c), consensus (85c)
Premium
The Fly
Axsome Therapeutics reports Q2 EPS (99c), consensus (85c)
29d ago
AXSM
These Are the Stocks Reporting Earnings Today – August 10, 2026
Premium
Market News
These Are the Stocks Reporting Earnings Today – August 10, 2026
30d ago
B
DJT
AXSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
AXSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
AXSM
Axsome Therapeutics price target lowered to $306 from $310 at Mizuho
PremiumThe Fly
Axsome Therapeutics price target lowered to $306 from $310 at Mizuho
1M ago
AXSM
Axsome, Five Below, APPS, Intuit, Adobe Trending With Analysts
PremiumWeekend Updates
Axsome, Five Below, APPS, Intuit, Adobe Trending With Analysts
2M ago
ADBE
APPS
Axsome Advances AXS-14 Fibromyalgia Trial With New Long-Term Safety Update
PremiumCompany Announcements
Axsome Advances AXS-14 Fibromyalgia Trial With New Long-Term Safety Update
2M ago
AXSM
Axsome’s CLARITY Trial Targets Sleepy Depression: What Investors Should Watch
PremiumCompany AnnouncementsAxsome’s CLARITY Trial Targets Sleepy Depression: What Investors Should Watch
2M ago
AXSM
Axsome’s Phase 3 Fibromyalgia Trial of AXS-14 Takes Shape: What Investors Should Watch
Premium
Company Announcements
Axsome’s Phase 3 Fibromyalgia Trial of AXS-14 Takes Shape: What Investors Should Watch
2M ago
AXSM
Shopify downgraded, Five Below upgraded: Wall Street’s top analyst calls
Premium
The Fly
Shopify downgraded, Five Below upgraded: Wall Street’s top analyst calls
2M ago
GS
RL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >